APO Research
Talk to an analyst

APO RESEARCH · REPORT

Anti-Mullerian Hormone (AMH) Test

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Anti-Mullerian Hormone (AMH) Test Market Outlook and Growth Opportunities 2026

4 March 2026201 pages

Choose your research edition.

Industry ResearchAnti-Mullerian Hormone (AMH) Test Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Anti-Mullerian Hormone (AMH) Test Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Anti-Mullerian Hormone (AMH) Test Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anti-Mullerian Hormone (AMH) Test Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Anti-Mullerian Hormone (AMH) Test Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Anti-Mullerian Hormone (AMH) Test market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Anti-Mullerian Hormone (AMH) Test is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Anti-Mullerian Hormone (AMH) Test is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Anti-Mullerian Hormone (AMH) Test is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Anti-Mullerian Hormone (AMH) Test market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Anti-Mullerian Hormone (AMH) Test market include Roche, Beckman Coulter, BioMérieux, Monash IVF, Bumrungrad International Hospital, CTK Biotech, Biotime, Boditech Med and CREATE Fertility, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Anti-Mullerian Hormone (AMH) Test market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Anti-Mullerian Hormone (AMH) Test and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Anti-Mullerian Hormone (AMH) Test revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Anti-Mullerian Hormone (AMH) Test market.

Anti-Mullerian Hormone (AMH) Test Segment by Company

Roche

Beckman Coulter

BioMérieux

Monash IVF

Bumrungrad International Hospital

CTK Biotech

Biotime

Boditech Med

CREATE Fertility

Repromed Fertility Specialists

Quest Health

Clinpath Pathology

Shenzhen YHLO Biotech

Guangzhou Kangrun Biotechnology

Guangzhou Wondfo Biotech

Beijing Savant Biotechnology

Anti-Mullerian Hormone (AMH) Test Segment by Type

Chemiluminescence Immunoassay

ELISA

Magnetic Particle Chemiluminescence

Flow Cytometry Fluorescence Luminescence

Other

Anti-Mullerian Hormone (AMH) Test Segment by Application

Assisted Reproduction

Polycystic Ovary Syndrome

Ovarian Cancer

Other

Anti-Mullerian Hormone (AMH) Test Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Anti-Mullerian Hormone (AMH) Test status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Anti-Mullerian Hormone (AMH) Test key companies, revenue, market share, and recent developments.

3. To split the Anti-Mullerian Hormone (AMH) Test breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Anti-Mullerian Hormone (AMH) Test market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Anti-Mullerian Hormone (AMH) Test significant trends, drivers, influence factors in global and regions.

6. To analyze Anti-Mullerian Hormone (AMH) Test competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-Mullerian Hormone (AMH) Test market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anti-Mullerian Hormone (AMH) Test and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-Mullerian Hormone (AMH) Test.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Anti-Mullerian Hormone (AMH) Test industry.

Chapter 3: Detailed analysis of Anti-Mullerian Hormone (AMH) Test company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Anti-Mullerian Hormone (AMH) Test in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Anti-Mullerian Hormone (AMH) Test in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Anti-Mullerian Hormone (AMH) Test Industry Trends Table 2. Anti-Mullerian Hormone (AMH) Test Industry Drivers Table 3. Anti-Mullerian Hormone (AMH) Test Industry Opportunities and Challenges Table 4. Anti-Mullerian Hormone (AMH) Test Industry Restraints Table 5. Global Anti-Mullerian Hormone (AMH) Test Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Anti-Mullerian Hormone (AMH) Test Revenue Share by Company (2021-2026) Table 7. Global Anti-Mullerian Hormone (AMH) Test Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Anti-Mullerian Hormone (AMH) Test Key Company Manufacturing Base & Headquarters Table 9. Global Anti-Mullerian Hormone (AMH) Test Company, Product Type & Application Table 10. Global Anti-Mullerian Hormone (AMH) Test Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Anti-Mullerian Hormone (AMH) Test by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Chemiluminescence Immunoassay Table 15. Significant Companies of ELISA Table 16. Significant Companies of Magnetic Particle Chemiluminescence Table 17. Significant Companies of Flow Cytometry Fluorescence Luminescence Table 18. Significant Companies of Other Table 19. Global Anti-Mullerian Hormone (AMH) Test Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 20. Global Anti-Mullerian Hormone (AMH) Test Sales Value by Type (2021-2026) & (US$ Million) Table 21. Global Anti-Mullerian Hormone (AMH) Test Sales Value by Type (2027-2032) & (US$ Million) Table 22. Global Anti-Mullerian Hormone (AMH) Test Sales Value Share by Type (2021-2026) Table 23. Global Anti-Mullerian Hormone (AMH) Test Sales Value Share by Type (2027-2032) Table 24. Significant Companies of Assisted Reproduction Table 25. Significant Companies of Polycystic Ovary Syndrome Table 26. Significant Companies of Ovarian Cancer Table 27. Significant Companies of Other Table 28. Global Anti-Mullerian Hormone (AMH) Test Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Anti-Mullerian Hormone (AMH) Test Sales Value by Application (2021-2026) & (US$ Million) Table 30. Global Anti-Mullerian Hormone (AMH) Test Sales Value by Application (2027-2032) & (US$ Million) Table 31. Global Anti-Mullerian Hormone (AMH) Test Sales Value Share by Application (2021-2026) Table 32. Global Anti-Mullerian Hormone (AMH) Test Sales Value Share by Application (2027-2032) Table 33. Global Anti-Mullerian Hormone (AMH) Test Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Anti-Mullerian Hormone (AMH) Test Sales Value by Region (2021-2026) & (US$ Million) Table 35. Global Anti-Mullerian Hormone (AMH) Test Sales Value Share by Region (2021-2026) Table 36. Global Anti-Mullerian Hormone (AMH) Test Sales Value by Region (2027-2032) & (US$ Million) Table 37. Global Anti-Mullerian Hormone (AMH) Test Sales Value Share by Region (2027-2032) Table 38. Global Anti-Mullerian Hormone (AMH) Test Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Anti-Mullerian Hormone (AMH) Test Sales Value by Country (2021-2026) & (US$ Million) Table 40. Global Anti-Mullerian Hormone (AMH) Test Sales Value Market Share by Country (2021-2026) Table 41. Global Anti-Mullerian Hormone (AMH) Test Sales Value by Country (2027-2032) & (US$ Million) Table 42. Global Anti-Mullerian Hormone (AMH) Test Sales Value Market Share by Country (2027-2032) Table 43. Roche Company Information Table 44. Roche Business Overview Table 45. Roche Anti-Mullerian Hormone (AMH) Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Roche Anti-Mullerian Hormone (AMH) Test Product Portfolio Table 47. Roche Recent Development Table 48. Beckman Coulter Company Information Table 49. Beckman Coulter Business Overview Table 50. Beckman Coulter Anti-Mullerian Hormone (AMH) Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Beckman Coulter Anti-Mullerian Hormone (AMH) Test Product Portfolio Table 52. Beckman Coulter Recent Development Table 53. BioMérieux Company Information Table 54. BioMérieux Business Overview Table 55. BioMérieux Anti-Mullerian Hormone (AMH) Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. BioMérieux Anti-Mullerian Hormone (AMH) Test Product Portfolio Table 57. BioMérieux Recent Development Table 58. Monash IVF Company Information Table 59. Monash IVF Business Overview Table 60. Monash IVF Anti-Mullerian Hormone (AMH) Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Monash IVF Anti-Mullerian Hormone (AMH) Test Product Portfolio Table 62. Monash IVF Recent Development Table 63. Bumrungrad International Hospital Company Information Table 64. Bumrungrad International Hospital Business Overview Table 65. Bumrungrad International Hospital Anti-Mullerian Hormone (AMH) Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Bumrungrad International Hospital Anti-Mullerian Hormone (AMH) Test Product Portfolio Table 67. Bumrungrad International Hospital Recent Development Table 68. CTK Biotech Company Information Table 69. CTK Biotech Business Overview Table 70. CTK Biotech Anti-Mullerian Hormone (AMH) Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. CTK Biotech Anti-Mullerian Hormone (AMH) Test Product Portfolio Table 72. CTK Biotech Recent Development Table 73. Biotime Company Information Table 74. Biotime Business Overview Table 75. Biotime Anti-Mullerian Hormone (AMH) Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Biotime Anti-Mullerian Hormone (AMH) Test Product Portfolio Table 77. Biotime Recent Development Table 78. Boditech Med Company Information Table 79. Boditech Med Business Overview Table 80. Boditech Med Anti-Mullerian Hormone (AMH) Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Boditech Med Anti-Mullerian Hormone (AMH) Test Product Portfolio Table 82. Boditech Med Recent Development Table 83. CREATE Fertility Company Information Table 84. CREATE Fertility Business Overview Table 85. CREATE Fertility Anti-Mullerian Hormone (AMH) Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. CREATE Fertility Anti-Mullerian Hormone (AMH) Test Product Portfolio Table 87. CREATE Fertility Recent Development Table 88. Repromed Fertility Specialists Company Information Table 89. Repromed Fertility Specialists Business Overview Table 90. Repromed Fertility Specialists Anti-Mullerian Hormone (AMH) Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Repromed Fertility Specialists Anti-Mullerian Hormone (AMH) Test Product Portfolio Table 92. Repromed Fertility Specialists Recent Development Table 93. Quest Health Company Information Table 94. Quest Health Business Overview Table 95. Quest Health Anti-Mullerian Hormone (AMH) Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Quest Health Anti-Mullerian Hormone (AMH) Test Product Portfolio Table 97. Quest Health Recent Development Table 98. Clinpath Pathology Company Information Table 99. Clinpath Pathology Business Overview Table 100. Clinpath Pathology Anti-Mullerian Hormone (AMH) Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Clinpath Pathology Anti-Mullerian Hormone (AMH) Test Product Portfolio Table 102. Clinpath Pathology Recent Development Table 103. Shenzhen YHLO Biotech Company Information Table 104. Shenzhen YHLO Biotech Business Overview Table 105. Shenzhen YHLO Biotech Anti-Mullerian Hormone (AMH) Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Shenzhen YHLO Biotech Anti-Mullerian Hormone (AMH) Test Product Portfolio Table 107. Shenzhen YHLO Biotech Recent Development Table 108. Guangzhou Kangrun Biotechnology Company Information Table 109. Guangzhou Kangrun Biotechnology Business Overview Table 110. Guangzhou Kangrun Biotechnology Anti-Mullerian Hormone (AMH) Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Guangzhou Kangrun Biotechnology Anti-Mullerian Hormone (AMH) Test Product Portfolio Table 112. Guangzhou Kangrun Biotechnology Recent Development Table 113. Guangzhou Wondfo Biotech Company Information Table 114. Guangzhou Wondfo Biotech Business Overview Table 115. Guangzhou Wondfo Biotech Anti-Mullerian Hormone (AMH) Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. Guangzhou Wondfo Biotech Anti-Mullerian Hormone (AMH) Test Product Portfolio Table 117. Guangzhou Wondfo Biotech Recent Development Table 118. Beijing Savant Biotechnology Company Information Table 119. Beijing Savant Biotechnology Business Overview Table 120. Beijing Savant Biotechnology Anti-Mullerian Hormone (AMH) Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. Beijing Savant Biotechnology Anti-Mullerian Hormone (AMH) Test Product Portfolio Table 122. Beijing Savant Biotechnology Recent Development Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources Table 126. Primary Sources List of Figures Figure 1. Anti-Mullerian Hormone (AMH) Test Product Image Figure 2. Global Anti-Mullerian Hormone (AMH) Test Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anti-Mullerian Hormone (AMH) Test Market Size (2021-2032) & (US$ Million) Figure 4. Global Anti-Mullerian Hormone (AMH) Test Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Chemiluminescence Immunoassay Image Figure 8. ELISA Image Figure 9. Magnetic Particle Chemiluminescence Image Figure 10. Flow Cytometry Fluorescence Luminescence Image Figure 11. Other Image Figure 12. Global Anti-Mullerian Hormone (AMH) Test Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 13. Global Anti-Mullerian Hormone (AMH) Test Sales Value Share 2021 VS 2025 VS 2032 Figure 14. Global Anti-Mullerian Hormone (AMH) Test Sales Value Share by Type (2021-2032) Figure 15. Assisted Reproduction Image Figure 16. Polycystic Ovary Syndrome Image Figure 17. Ovarian Cancer Image Figure 18. Other Image Figure 19. Global Anti-Mullerian Hormone (AMH) Test Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Anti-Mullerian Hormone (AMH) Test Sales Value Share 2021 VS 2025 VS 2032 Figure 21. Global Anti-Mullerian Hormone (AMH) Test Sales Value Share by Application (2021-2032) Figure 22. Global Anti-Mullerian Hormone (AMH) Test Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 23. Global Anti-Mullerian Hormone (AMH) Test Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 24. North America Anti-Mullerian Hormone (AMH) Test Sales Value (2021-2032) & (US$ Million) Figure 25. North America Anti-Mullerian Hormone (AMH) Test Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Europe Anti-Mullerian Hormone (AMH) Test Sales Value (2021-2032) & (US$ Million) Figure 27. Europe Anti-Mullerian Hormone (AMH) Test Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Asia-Pacific Anti-Mullerian Hormone (AMH) Test Sales Value (2021-2032) & (US$ Million) Figure 29. Asia-Pacific Anti-Mullerian Hormone (AMH) Test Sales Value Share by Country (%), 2025 VS 2032 Figure 30. South America Anti-Mullerian Hormone (AMH) Test Sales Value (2021-2032) & (US$ Million) Figure 31. South America Anti-Mullerian Hormone (AMH) Test Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Middle East & Africa Anti-Mullerian Hormone (AMH) Test Sales Value (2021-2032) & (US$ Million) Figure 33. Middle East & Africa Anti-Mullerian Hormone (AMH) Test Sales Value Share by Country (%), 2025 VS 2032 Figure 34. USA Anti-Mullerian Hormone (AMH) Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. USA Anti-Mullerian Hormone (AMH) Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. USA Anti-Mullerian Hormone (AMH) Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Canada Anti-Mullerian Hormone (AMH) Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Canada Anti-Mullerian Hormone (AMH) Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Canada Anti-Mullerian Hormone (AMH) Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Mexico Anti-Mullerian Hormone (AMH) Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Mexico Anti-Mullerian Hormone (AMH) Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Mexico Anti-Mullerian Hormone (AMH) Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Germany Anti-Mullerian Hormone (AMH) Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Germany Anti-Mullerian Hormone (AMH) Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Germany Anti-Mullerian Hormone (AMH) Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. France Anti-Mullerian Hormone (AMH) Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. France Anti-Mullerian Hormone (AMH) Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. France Anti-Mullerian Hormone (AMH) Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. U.K. Anti-Mullerian Hormone (AMH) Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. U.K. Anti-Mullerian Hormone (AMH) Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. U.K. Anti-Mullerian Hormone (AMH) Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Italy Anti-Mullerian Hormone (AMH) Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Italy Anti-Mullerian Hormone (AMH) Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Italy Anti-Mullerian Hormone (AMH) Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Spain Anti-Mullerian Hormone (AMH) Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Spain Anti-Mullerian Hormone (AMH) Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Spain Anti-Mullerian Hormone (AMH) Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Russia Anti-Mullerian Hormone (AMH) Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Russia Anti-Mullerian Hormone (AMH) Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Russia Anti-Mullerian Hormone (AMH) Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Netherlands Anti-Mullerian Hormone (AMH) Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Netherlands Anti-Mullerian Hormone (AMH) Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Netherlands Anti-Mullerian Hormone (AMH) Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Nordic Countries Anti-Mullerian Hormone (AMH) Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Nordic Countries Anti-Mullerian Hormone (AMH) Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Nordic Countries Anti-Mullerian Hormone (AMH) Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. China Anti-Mullerian Hormone (AMH) Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. China Anti-Mullerian Hormone (AMH) Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. China Anti-Mullerian Hormone (AMH) Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Japan Anti-Mullerian Hormone (AMH) Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Japan Anti-Mullerian Hormone (AMH) Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Japan Anti-Mullerian Hormone (AMH) Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. South Korea Anti-Mullerian Hormone (AMH) Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. South Korea Anti-Mullerian Hormone (AMH) Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. South Korea Anti-Mullerian Hormone (AMH) Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. India Anti-Mullerian Hormone (AMH) Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. India Anti-Mullerian Hormone (AMH) Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. India Anti-Mullerian Hormone (AMH) Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Australia Anti-Mullerian Hormone (AMH) Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Australia Anti-Mullerian Hormone (AMH) Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Australia Anti-Mullerian Hormone (AMH) Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Southeast Asia Anti-Mullerian Hormone (AMH) Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Southeast Asia Anti-Mullerian Hormone (AMH) Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Southeast Asia Anti-Mullerian Hormone (AMH) Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Brazil Anti-Mullerian Hormone (AMH) Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Brazil Anti-Mullerian Hormone (AMH) Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Brazil Anti-Mullerian Hormone (AMH) Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Argentina Anti-Mullerian Hormone (AMH) Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Argentina Anti-Mullerian Hormone (AMH) Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Argentina Anti-Mullerian Hormone (AMH) Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Chile Anti-Mullerian Hormone (AMH) Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Chile Anti-Mullerian Hormone (AMH) Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Chile Anti-Mullerian Hormone (AMH) Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Colombia Anti-Mullerian Hormone (AMH) Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Colombia Anti-Mullerian Hormone (AMH) Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Colombia Anti-Mullerian Hormone (AMH) Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Peru Anti-Mullerian Hormone (AMH) Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Peru Anti-Mullerian Hormone (AMH) Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Peru Anti-Mullerian Hormone (AMH) Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Anti-Mullerian Hormone (AMH) Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Saudi Arabia Anti-Mullerian Hormone (AMH) Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Saudi Arabia Anti-Mullerian Hormone (AMH) Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Israel Anti-Mullerian Hormone (AMH) Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Israel Anti-Mullerian Hormone (AMH) Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Israel Anti-Mullerian Hormone (AMH) Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. UAE Anti-Mullerian Hormone (AMH) Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. UAE Anti-Mullerian Hormone (AMH) Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. UAE Anti-Mullerian Hormone (AMH) Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Turkey Anti-Mullerian Hormone (AMH) Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Turkey Anti-Mullerian Hormone (AMH) Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Turkey Anti-Mullerian Hormone (AMH) Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Iran Anti-Mullerian Hormone (AMH) Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Iran Anti-Mullerian Hormone (AMH) Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Iran Anti-Mullerian Hormone (AMH) Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Egypt Anti-Mullerian Hormone (AMH) Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Egypt Anti-Mullerian Hormone (AMH) Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Egypt Anti-Mullerian Hormone (AMH) Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Years Considered Figure 119. Research Process Figure 120. Key Executives Interviewed

Scope & coverage.

Types
  • Chemiluminescence Immunoassay
  • ELISA
  • Magnetic Particle Chemiluminescence
  • Flow Cytometry Fluorescence Luminescence
  • Other
Applications
  • Assisted Reproduction
  • Polycystic Ovary Syndrome
  • Ovarian Cancer
  • Other
Companies covered
  • Roche
  • Beckman Coulter
  • BioMérieux
  • Monash IVF
  • Bumrungrad International Hospital
  • CTK Biotech
  • Biotime
  • Boditech Med
  • CREATE Fertility
  • Repromed Fertility Specialists
  • Quest Health
  • Clinpath Pathology
  • Shenzhen YHLO Biotech
  • Guangzhou Kangrun Biotechnology
  • Guangzhou Wondfo Biotech
  • Beijing Savant Biotechnology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Anti-Mullerian Hormone (AMH) Test Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Anti-Mullerian Hormone (AMH) Test Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Anti-Mullerian Hormone (AMH) Test Market Dynamics
  1. 2.1 Anti-Mullerian Hormone (AMH) Test Industry Trends
  2. 2.2 Anti-Mullerian Hormone (AMH) Test Industry Drivers
  3. 2.3 Anti-Mullerian Hormone (AMH) Test Industry Opportunities and Challenges
  4. 2.4 Anti-Mullerian Hormone (AMH) Test Industry Restraints
3 Anti-Mullerian Hormone (AMH) Test Market by Company
  1. 3.1 Global Anti-Mullerian Hormone (AMH) Test Company Revenue Ranking in 2025
  2. 3.2 Global Anti-Mullerian Hormone (AMH) Test Revenue by Company (2021-2026)
  3. 3.3 Global Anti-Mullerian Hormone (AMH) Test Company Ranking (2024-2026)
  4. 3.4 Global Anti-Mullerian Hormone (AMH) Test Company Manufacturing Base and Headquarters
  5. 3.5 Global Anti-Mullerian Hormone (AMH) Test Company Product Type and Application
  6. 3.6 Global Anti-Mullerian Hormone (AMH) Test Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Anti-Mullerian Hormone (AMH) Test Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Anti-Mullerian Hormone (AMH) Test Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Anti-Mullerian Hormone (AMH) Test Market by Type
  1. 4.1 Anti-Mullerian Hormone (AMH) Test Type Introduction
  2. 4.1.1 Chemiluminescence Immunoassay
  3. 4.1.2 ELISA
  4. 4.1.3 Magnetic Particle Chemiluminescence
  5. 4.1.4 Flow Cytometry Fluorescence Luminescence
  6. 4.1.5 Other
  7. 4.2 Global Anti-Mullerian Hormone (AMH) Test Sales Value by Type
  8. 4.2.1 Global Anti-Mullerian Hormone (AMH) Test Sales Value by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Anti-Mullerian Hormone (AMH) Test Sales Value by Type (2021-2032)
  10. 4.2.3 Global Anti-Mullerian Hormone (AMH) Test Sales Value Share by Type (2021-2032)
5 Anti-Mullerian Hormone (AMH) Test Market by Application
  1. 5.1 Anti-Mullerian Hormone (AMH) Test Application Introduction
  2. 5.1.1 Assisted Reproduction
  3. 5.1.2 Polycystic Ovary Syndrome
  4. 5.1.3 Ovarian Cancer
  5. 5.1.4 Other
  6. 5.2 Global Anti-Mullerian Hormone (AMH) Test Sales Value by Application
  7. 5.2.1 Global Anti-Mullerian Hormone (AMH) Test Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Anti-Mullerian Hormone (AMH) Test Sales Value by Application (2021-2032)
  9. 5.2.3 Global Anti-Mullerian Hormone (AMH) Test Sales Value Share by Application (2021-2032)
6 Anti-Mullerian Hormone (AMH) Test Regional Value Analysis
  1. 6.1 Global Anti-Mullerian Hormone (AMH) Test Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Anti-Mullerian Hormone (AMH) Test Sales Value by Region (2021-2032)
  3. 6.2.1 Global Anti-Mullerian Hormone (AMH) Test Sales Value by Region: 2021-2026
  4. 6.2.2 Global Anti-Mullerian Hormone (AMH) Test Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Anti-Mullerian Hormone (AMH) Test Sales Value (2021-2032)
  7. 6.3.2 North America Anti-Mullerian Hormone (AMH) Test Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Anti-Mullerian Hormone (AMH) Test Sales Value (2021-2032)
  10. 6.4.2 Europe Anti-Mullerian Hormone (AMH) Test Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Anti-Mullerian Hormone (AMH) Test Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Anti-Mullerian Hormone (AMH) Test Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Anti-Mullerian Hormone (AMH) Test Sales Value (2021-2032)
  16. 6.6.2 South America Anti-Mullerian Hormone (AMH) Test Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Anti-Mullerian Hormone (AMH) Test Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Anti-Mullerian Hormone (AMH) Test Sales Value Share by Country, 2025 VS 2032
7 Anti-Mullerian Hormone (AMH) Test Country-level Value Analysis
  1. 7.1 Global Anti-Mullerian Hormone (AMH) Test Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Anti-Mullerian Hormone (AMH) Test Sales Value by Country (2021-2032)
  3. 7.2.1 Global Anti-Mullerian Hormone (AMH) Test Sales Value by Country (2021-2026)
  4. 7.2.2 Global Anti-Mullerian Hormone (AMH) Test Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Anti-Mullerian Hormone (AMH) Test Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Anti-Mullerian Hormone (AMH) Test Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Anti-Mullerian Hormone (AMH) Test Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Anti-Mullerian Hormone (AMH) Test Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Anti-Mullerian Hormone (AMH) Test Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Anti-Mullerian Hormone (AMH) Test Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Anti-Mullerian Hormone (AMH) Test Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Anti-Mullerian Hormone (AMH) Test Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Anti-Mullerian Hormone (AMH) Test Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Anti-Mullerian Hormone (AMH) Test Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Anti-Mullerian Hormone (AMH) Test Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Anti-Mullerian Hormone (AMH) Test Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Anti-Mullerian Hormone (AMH) Test Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Anti-Mullerian Hormone (AMH) Test Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Anti-Mullerian Hormone (AMH) Test Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Anti-Mullerian Hormone (AMH) Test Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Anti-Mullerian Hormone (AMH) Test Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Anti-Mullerian Hormone (AMH) Test Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Anti-Mullerian Hormone (AMH) Test Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Anti-Mullerian Hormone (AMH) Test Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Anti-Mullerian Hormone (AMH) Test Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Anti-Mullerian Hormone (AMH) Test Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Anti-Mullerian Hormone (AMH) Test Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Anti-Mullerian Hormone (AMH) Test Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Anti-Mullerian Hormone (AMH) Test Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Anti-Mullerian Hormone (AMH) Test Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Anti-Mullerian Hormone (AMH) Test Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Anti-Mullerian Hormone (AMH) Test Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Anti-Mullerian Hormone (AMH) Test Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Anti-Mullerian Hormone (AMH) Test Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Anti-Mullerian Hormone (AMH) Test Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Anti-Mullerian Hormone (AMH) Test Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Anti-Mullerian Hormone (AMH) Test Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Anti-Mullerian Hormone (AMH) Test Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Anti-Mullerian Hormone (AMH) Test Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Anti-Mullerian Hormone (AMH) Test Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Anti-Mullerian Hormone (AMH) Test Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Anti-Mullerian Hormone (AMH) Test Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Anti-Mullerian Hormone (AMH) Test Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Anti-Mullerian Hormone (AMH) Test Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Anti-Mullerian Hormone (AMH) Test Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Anti-Mullerian Hormone (AMH) Test Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Anti-Mullerian Hormone (AMH) Test Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Anti-Mullerian Hormone (AMH) Test Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Anti-Mullerian Hormone (AMH) Test Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Anti-Mullerian Hormone (AMH) Test Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Anti-Mullerian Hormone (AMH) Test Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Anti-Mullerian Hormone (AMH) Test Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Anti-Mullerian Hormone (AMH) Test Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Anti-Mullerian Hormone (AMH) Test Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Anti-Mullerian Hormone (AMH) Test Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Anti-Mullerian Hormone (AMH) Test Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Anti-Mullerian Hormone (AMH) Test Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Anti-Mullerian Hormone (AMH) Test Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Anti-Mullerian Hormone (AMH) Test Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Anti-Mullerian Hormone (AMH) Test Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Anti-Mullerian Hormone (AMH) Test Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Anti-Mullerian Hormone (AMH) Test Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Anti-Mullerian Hormone (AMH) Test Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Anti-Mullerian Hormone (AMH) Test Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Anti-Mullerian Hormone (AMH) Test Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Anti-Mullerian Hormone (AMH) Test Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Anti-Mullerian Hormone (AMH) Test Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Anti-Mullerian Hormone (AMH) Test Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Anti-Mullerian Hormone (AMH) Test Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Anti-Mullerian Hormone (AMH) Test Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Anti-Mullerian Hormone (AMH) Test Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Anti-Mullerian Hormone (AMH) Test Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Anti-Mullerian Hormone (AMH) Test Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Anti-Mullerian Hormone (AMH) Test Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Anti-Mullerian Hormone (AMH) Test Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Anti-Mullerian Hormone (AMH) Test Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Anti-Mullerian Hormone (AMH) Test Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Anti-Mullerian Hormone (AMH) Test Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Anti-Mullerian Hormone (AMH) Test Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Anti-Mullerian Hormone (AMH) Test Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Anti-Mullerian Hormone (AMH) Test Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Anti-Mullerian Hormone (AMH) Test Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Anti-Mullerian Hormone (AMH) Test Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Anti-Mullerian Hormone (AMH) Test Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Anti-Mullerian Hormone (AMH) Test Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Anti-Mullerian Hormone (AMH) Test Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Anti-Mullerian Hormone (AMH) Test Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Anti-Mullerian Hormone (AMH) Test Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Roche
  2. 8.1.1 Roche Company Information
  3. 8.1.2 Roche Business Overview
  4. 8.1.3 Roche Anti-Mullerian Hormone (AMH) Test Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Roche Anti-Mullerian Hormone (AMH) Test Product Portfolio
  6. 8.1.5 Roche Recent Developments
  7. 8.2 Beckman Coulter
  8. 8.2.1 Beckman Coulter Company Information
  9. 8.2.2 Beckman Coulter Business Overview
  10. 8.2.3 Beckman Coulter Anti-Mullerian Hormone (AMH) Test Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Beckman Coulter Anti-Mullerian Hormone (AMH) Test Product Portfolio
  12. 8.2.5 Beckman Coulter Recent Developments
  13. 8.3 BioMérieux
  14. 8.3.1 BioMérieux Company Information
  15. 8.3.2 BioMérieux Business Overview
  16. 8.3.3 BioMérieux Anti-Mullerian Hormone (AMH) Test Revenue and Gross Margin (2021-2026)
  17. 8.3.4 BioMérieux Anti-Mullerian Hormone (AMH) Test Product Portfolio
  18. 8.3.5 BioMérieux Recent Developments
  19. 8.4 Monash IVF
  20. 8.4.1 Monash IVF Company Information
  21. 8.4.2 Monash IVF Business Overview
  22. 8.4.3 Monash IVF Anti-Mullerian Hormone (AMH) Test Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Monash IVF Anti-Mullerian Hormone (AMH) Test Product Portfolio
  24. 8.4.5 Monash IVF Recent Developments
  25. 8.5 Bumrungrad International Hospital
  26. 8.5.1 Bumrungrad International Hospital Company Information
  27. 8.5.2 Bumrungrad International Hospital Business Overview
  28. 8.5.3 Bumrungrad International Hospital Anti-Mullerian Hormone (AMH) Test Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Bumrungrad International Hospital Anti-Mullerian Hormone (AMH) Test Product Portfolio
  30. 8.5.5 Bumrungrad International Hospital Recent Developments
  31. 8.6 CTK Biotech
  32. 8.6.1 CTK Biotech Company Information
  33. 8.6.2 CTK Biotech Business Overview
  34. 8.6.3 CTK Biotech Anti-Mullerian Hormone (AMH) Test Revenue and Gross Margin (2021-2026)
  35. 8.6.4 CTK Biotech Anti-Mullerian Hormone (AMH) Test Product Portfolio
  36. 8.6.5 CTK Biotech Recent Developments
  37. 8.7 Biotime
  38. 8.7.1 Biotime Company Information
  39. 8.7.2 Biotime Business Overview
  40. 8.7.3 Biotime Anti-Mullerian Hormone (AMH) Test Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Biotime Anti-Mullerian Hormone (AMH) Test Product Portfolio
  42. 8.7.5 Biotime Recent Developments
  43. 8.8 Boditech Med
  44. 8.8.1 Boditech Med Company Information
  45. 8.8.2 Boditech Med Business Overview
  46. 8.8.3 Boditech Med Anti-Mullerian Hormone (AMH) Test Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Boditech Med Anti-Mullerian Hormone (AMH) Test Product Portfolio
  48. 8.8.5 Boditech Med Recent Developments
  49. 8.9 CREATE Fertility
  50. 8.9.1 CREATE Fertility Company Information
  51. 8.9.2 CREATE Fertility Business Overview
  52. 8.9.3 CREATE Fertility Anti-Mullerian Hormone (AMH) Test Revenue and Gross Margin (2021-2026)
  53. 8.9.4 CREATE Fertility Anti-Mullerian Hormone (AMH) Test Product Portfolio
  54. 8.9.5 CREATE Fertility Recent Developments
  55. 8.10 Repromed Fertility Specialists
  56. 8.10.1 Repromed Fertility Specialists Company Information
  57. 8.10.2 Repromed Fertility Specialists Business Overview
  58. 8.10.3 Repromed Fertility Specialists Anti-Mullerian Hormone (AMH) Test Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Repromed Fertility Specialists Anti-Mullerian Hormone (AMH) Test Product Portfolio
  60. 8.10.5 Repromed Fertility Specialists Recent Developments
  61. 8.11 Quest Health
  62. 8.11.1 Quest Health Company Information
  63. 8.11.2 Quest Health Business Overview
  64. 8.11.3 Quest Health Anti-Mullerian Hormone (AMH) Test Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Quest Health Anti-Mullerian Hormone (AMH) Test Product Portfolio
  66. 8.11.5 Quest Health Recent Developments
  67. 8.12 Clinpath Pathology
  68. 8.12.1 Clinpath Pathology Company Information
  69. 8.12.2 Clinpath Pathology Business Overview
  70. 8.12.3 Clinpath Pathology Anti-Mullerian Hormone (AMH) Test Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Clinpath Pathology Anti-Mullerian Hormone (AMH) Test Product Portfolio
  72. 8.12.5 Clinpath Pathology Recent Developments
  73. 8.13 Shenzhen YHLO Biotech
  74. 8.13.1 Shenzhen YHLO Biotech Company Information
  75. 8.13.2 Shenzhen YHLO Biotech Business Overview
  76. 8.13.3 Shenzhen YHLO Biotech Anti-Mullerian Hormone (AMH) Test Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Shenzhen YHLO Biotech Anti-Mullerian Hormone (AMH) Test Product Portfolio
  78. 8.13.5 Shenzhen YHLO Biotech Recent Developments
  79. 8.14 Guangzhou Kangrun Biotechnology
  80. 8.14.1 Guangzhou Kangrun Biotechnology Company Information
  81. 8.14.2 Guangzhou Kangrun Biotechnology Business Overview
  82. 8.14.3 Guangzhou Kangrun Biotechnology Anti-Mullerian Hormone (AMH) Test Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Guangzhou Kangrun Biotechnology Anti-Mullerian Hormone (AMH) Test Product Portfolio
  84. 8.14.5 Guangzhou Kangrun Biotechnology Recent Developments
  85. 8.15 Guangzhou Wondfo Biotech
  86. 8.15.1 Guangzhou Wondfo Biotech Company Information
  87. 8.15.2 Guangzhou Wondfo Biotech Business Overview
  88. 8.15.3 Guangzhou Wondfo Biotech Anti-Mullerian Hormone (AMH) Test Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Guangzhou Wondfo Biotech Anti-Mullerian Hormone (AMH) Test Product Portfolio
  90. 8.15.5 Guangzhou Wondfo Biotech Recent Developments
  91. 8.16 Beijing Savant Biotechnology
  92. 8.16.1 Beijing Savant Biotechnology Company Information
  93. 8.16.2 Beijing Savant Biotechnology Business Overview
  94. 8.16.3 Beijing Savant Biotechnology Anti-Mullerian Hormone (AMH) Test Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Beijing Savant Biotechnology Anti-Mullerian Hormone (AMH) Test Product Portfolio
  96. 8.16.5 Beijing Savant Biotechnology Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst